Physiological versus synthetic oestrogen therapy and bone mineral density in premature ovarian insufficiency

2018 ◽  
Author(s):  
Eileen Chen ◽  
Ian Seetho ◽  
Jane MacDougall
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Premature Ovarian Insufficiency ◽  
Oestrogen Therapy ◽  
Mineral Density ◽  
Ovarian Insufficiency

Premature ovarian insufficiency in young girls: repercussions on uterine volume and bone mineral density

2014 ◽  
Vol 31 (1) ◽  
pp. 65-69 ◽  
Author(s):  
Hanadi Bakhsh ◽  
Metella Dei ◽  
Sandra Bucciantini ◽  
Daniela Balzi ◽  
Vincenzina Bruni
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Premature Ovarian Insufficiency ◽  
Mineral Density ◽  
Ovarian Insufficiency ◽  
Young Girls ◽  
Uterine Volume

Timely diagnosis is vital: The effect of delayed diagnosis on bone mineral density in women with premature ovarian insufficiency

Maturitas ◽  
2017 ◽  
Vol 100 ◽  
pp. 199-200
Author(s):  
Kate Maclaran ◽  
Marie Gerval ◽  
Laura Cucinella ◽  
Geetika Shah ◽  
Winston Banya ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Delayed Diagnosis ◽  
Premature Ovarian Insufficiency ◽  
Mineral Density ◽  
Ovarian Insufficiency ◽  
Timely Diagnosis

scholarly journals Poor Compliance to Hormone Therapy and Decreased Bone Mineral Density in Women with Premature Ovarian Insufficiency

PLoS ONE ◽  
2016 ◽  
Vol 11 (12) ◽  
pp. e0164638 ◽  
Author(s):  
Anne Bachelot ◽  
Carole Nicolas ◽  
Solenne Gricourt ◽  
Jérôme Dulon ◽  
Monique Leban ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Hormone Therapy ◽  
Bone Mineral ◽  
Poor Compliance ◽  
Premature Ovarian Insufficiency ◽  
Mineral Density ◽  
Ovarian Insufficiency

Evaluation of basal bone mineral density (BMD) in premature ovarian insufficiency (POI) patients. Preliminary results. (Protocol code IIBSP-IOP-2012-109. ClinicalTrials.gov ID:NCT02068976)

Maturitas ◽  
2021 ◽  
Vol 152 ◽  
pp. 76
Author(s):  
Patricia Muro Blanc ◽  
Misericordia Guinot Gasull ◽  
Laura Balcells Eichenberger ◽  
Elisabet Robert Marchal ◽  
Beatriz Roca Comella ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Premature Ovarian Insufficiency ◽  
Mineral Density ◽  
Ovarian Insufficiency ◽  
Preliminary Results ◽  
Basal Bone

scholarly journals Effect of oral and transdermal oestrogen therapy on bone mineral density in functional hypothalamic amenorrhoea: a systematic review and meta-analysis

2021 ◽  
Vol 7 (3) ◽  
pp. e001112
Author(s):  
Karoline Aalberg ◽  
Knut Stavem ◽  
Frode Norheim ◽  
Michael Bjørn Russell ◽  
Aleksander Chaibi
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Female Athletes ◽  
Meta Analysis ◽  
Premenopausal Women ◽  
Cochrane Library ◽  
Oestrogen Therapy ◽  
Mineral Density ◽  
Vigorous Exercise ◽  
Serious Adverse Events

BackgroundFemale athletes might develop reduced bone mineral density (BMD) and amenorrhoea due to low energy intake.ObjectiveTo systematically review the literature of randomised controlled trials (RCTs) assessing the effect of oestrogen oral contraceptives (OCP), conjugated oestrogens (CE) and transdermal estradiol (TE) on BMD in premenopausal women with functional hypothalamic amenorrhoea (FHA) due to weight loss, vigorous exercise and/or stress.MethodsA comprehensive literature search in PubMed, MEDLINE, Cochrane Library, Ovid and CINAHL from inception to 1 October 2020.Data extraction and synthesisTwo authors independently extracted data. When possible, the data were pooled in a random-effects meta-analysis.Main outcomesDifference in BMD (g/cm2) at the lumbar spine.ResultsNine RCTs comprising 770 participants met the inclusion criteria; five studies applied OCP, two CE and two TE. Four RCTs (two OCP, two TE) found an increased BMD in premenopausal women with FHA, and five (three OCP, two CE) found a decreased BMD compared with controls. A meta-analysis showed no difference in BMD between the treatment and control groups, (standardised mean difference (SMD) 0.30, 95% CI −0.12 to 0.73). A secondary analysis for change scores from baseline to first assessment point, showed a similar overall result (SMD 0.17, 95% CI −0.16 to 0.51). No serious adverse events were reported.ConclusionThe literature suggests that TE might increase lumbar BMD in premenopausal women with FHA, but pooled results revealed no effect of the intervention. The findings do not support oestrogen therapy to improve BMD in these patient groups.

Relationship between serum calcium levels and bone mineral density in liver transplant receipients

2001 ◽  
Vol 120 (5) ◽  
pp. A564-A564
Author(s):  
K ISLAM ◽  
S CREECH ◽  
R SOKHI ◽  
R KONDAVEETI ◽  
A NADIR ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Liver Transplant ◽  
Bone Mineral ◽  
Serum Calcium ◽  
Mineral Density
Sign in / Sign up

Export Citation Format

Share Document